Immune Toxicities After CAR-T and Bispecific T-Cell Engager Therapies

Julia Carter, MD, Jonaphine Mata, MD, Thomas A Di Vitantonio, MD, Rupali Sood, MD, MPH, R Scott Stephens, MD, Kristina Montemayor, MD, MHS; Immune Toxiciti

Authors

Institutions

Publication Details

Journal
ATS Scholar
Published
2026-09-12
DOI
https://doi.org/10.1093/atsscholar/aapag058
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Immune Toxicities After CAR-T and Bispecific T-Cell Engager Therapies

Rupali Sood, T.A. Di Vitantonio, Kristina Montemayor, R. Scott Stephens et al.
ATS Scholar
CAR-T cell therapy research
article

Immune Toxicities After CAR-T and Bispecific T-Cell Engager Therapies

Rupali Sood, T.A. Di Vitantonio, Kristina Montemayor, R. Scott Stephens, Julia G. Carter, Jonaphine Mata
article en

Abstract

Julia Carter, MD, Jonaphine Mata, MD, Thomas A Di Vitantonio, MD, Rupali Sood, MD, MPH, R Scott Stephens, MD, Kristina Montemayor, MD, MHS; Immune Toxiciti

ATS Scholar
Johns Hopkins University (US), Johns Hopkins Medicine (US)
Good health and well-being
Openalex Percentile: Top 13%
CAR-T cell therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.